DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapidsmoking cessationphysical activitydietalcoholbehaviour change

Lifestyle intervention and smoking cessation

Essential points for quick revision.

Synopsis

Deliver measurable UK cardiovascular lifestyle intervention and evidence-based treatment of tobacco dependence.

  • Ask and record current tobacco and nicotine use at every relevant encounter; offer treatment rather than advice alone.
  • Combine behavioural support with an effective stop-smoking medicine when acceptable and suitable.
  • Adults should aim for at least 150 minutes of moderate or 75 minutes of vigorous activity weekly plus strength work on at least 2 days.

Key red flags

Exercise red flags

Exertional syncope, chest pain, disproportionate breathlessness or sustained palpitations requires cardiovascular assessment before vigorous exercise.

Investigation priorities

01
Smoking and nicotine historyFirst step

Define products, daily use, dependence, previous attempts and triggers.

Management branches

FirstBrief cardiovascular lifestyle intervention

Routine prevention, chronic disease review or a teachable clinical moment.

  1. Ask permission and assess smoking, diet, activity, alcohol, sleep, weight context and cardiovascular symptoms.
  2. Agree one personally meaningful SMART goal and specify how it will be measured.

Key medicines

VareniclineDays 1 to 3: 0.5 mg orally once daily; days 4 to 7: 0.5 mg twice daily; from day 8: 1 mg twice daily, usually for 12 weeks.
Combination nicotine replacement therapyTypical high-dependence regimen: 25 mg/16-hour nicotine patch once daily plus 2 mg gum or lozenge when cravings occur, within the selected product's maximum dose.
Open full textbook Answer 2 questionsCardiology check
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom